Related Experiment Video

Updated: May 26, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Personalizing treatment in type 2 diabetes: a self-monitoring of blood glucose inclusive innovative approach

Antonio Ceriello1, Marco Gallo, Vincenzo Armentano

  • 1Institute of Biomedical Investigations August Pi i Sunyer, Calle Mallorca 183, Barcelona, Spain. aceriell@clinic.ub.es

Diabetes Technology & Therapeutics
|January 6, 2012
PubMed

Insights

Personalized treatment plans improve diabetes management. Tailoring therapies based on individual patient factors like age and complications optimizes blood glucose control and prevents long-term issues.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Diabetes Management

Background:

  • Effective blood glucose control is crucial for preventing diabetes complications.
  • Individual patient variability means tight glycemic control doesn't benefit everyone equally.
  • Personalized approaches are needed for optimal diabetes care.

Purpose of the Study:

  • To propose tailored therapeutic algorithms for type 2 diabetes phenotypes.
  • To integrate patient-specific factors into diabetes management strategies.
  • To highlight the role of self-monitoring of blood glucose in personalized care.

Main Methods:

  • Development of therapeutic algorithms based on patient phenotypes.
  • Consideration of factors: age, BMI, micro/macrovascular complications, hypoglycemia risk, renal failure.
  • Utilizing self-monitoring of blood glucose data to guide treatment adjustments.

Main Results:

  • Personalized algorithms address common type 2 diabetes phenotypes.
  • Treatment tailoring considers diverse patient characteristics.
  • Self-monitoring data informs management of fasting/postprandial hyperglycemia.

Conclusions:

  • Tailored therapeutic algorithms can optimize diabetes management.
  • Individualized care plans are essential for effective type 2 diabetes treatment.
  • Self-monitoring of blood glucose is a key tool for personalized glycemic control.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...